Listen to the article
For 40 years, the Buoniconti Fund has defied expectations in its quest to cure paralysis, raising more than $550 million and expanding its research into multiple neurological conditions.
“We’re just not good listeners,” was how the late NFL Hall of Famer Nick Buoniconti explained their nonprofit’s success, according to his son Marc. The Buonicontis refused to accept that paralysis couldn’t be fixed, even when repeatedly told otherwise.
Marc Buoniconti, who was paralyzed during a routine tackle while playing as a college football linebacker at the Citadel four decades ago, attributes their longevity to sheer determination. “The Buoniconti Fund has lasted because we’re relentless,” he told The Associated Press. “We never give up. When we see a challenge, we face it head-on and don’t stop until we find a solution.”
That unwavering commitment has propelled The Miami Project to Cure Paralysis far beyond its original mission. Its research center at the University of Miami Miller School of Medicine now investigates a broad spectrum of neurological diseases and disorders, including Alzheimer’s and Parkinson’s. The center is also testing Elon Musk’s Neuralink brain-computer interface implant.
Dr. Barth A. Green, chairman of The Miami Project and co-founder of the organization alongside Nick Buoniconti in 1985, points to the initiative’s widespread impact on medicine. “Every operating room in the world that puts people to sleep monitors their nervous system for safety,” he noted. “That was all developed at The Miami Project.”
Another breakthrough from the center is therapeutic hypothermia—cooling the body after an injury to protect the brain and spinal cord—which has become a standard treatment worldwide.
Before the Buoniconti Fund created The Miami Project, there was no centralized hub for paralysis research. Dr. Green had been working in the field for two decades prior to Marc’s accident, but the establishment of the Miami Project created a home for “thousands of scientists and researchers in Miami and around the world” dedicated to improving quality of life for those with spinal injuries.
W. Dalton Dietrich III, Scientific Director at the Miami Project, credits the multidisciplinary approach for many of their unexpected advances. By bringing together neuroscientists, researchers, clinicians, and biomedical engineers under one roof, the center has fostered innovative solutions.
“Not one particular treatment is going to cure paralysis,” Dietrich explained. “So I’ve tried to look at other disciplines to bring into the project to help us achieve that goal.”
Neuromodulation represents one such emerging area that wasn’t on their radar five years ago. “It’s just an exciting area where you can stimulate these residual circuits after brain injury or spinal cord injury in patients and they start moving their limbs,” Dietrich said.
The Buoniconti Fund plays a crucial role in accelerating research by funding early trials, which later makes it easier to secure grants from government agencies like the National Institutes of Health or the Department of Defense.
For Marc Buoniconti, seeing so many people rally behind the cause has been deeply moving. “What started as a promise to help me walk again became a mission to help millions,” he said. “Every resource, every dollar, every hour given is a testament to the belief that we can change lives.”
That compelling mission has attracted high-profile supporters like legendary golfer Jack Nicklaus and Grammy winner Gloria Estefan. Mark Dalton, co-chairman of Tudor Investment Corp., was drawn to the cause even before meeting the Buonicontis.
“I had tremendous admiration for him as a father who was never going to give up on finding a cure for what ailed his son,” Dalton said, referring to Nick Buoniconti. “And his son was a representation of millions of other people.”
After learning more about The Miami Project, Dalton was particularly impressed by its science-driven approach and university campus setting. Now chairing the fund’s biggest annual fundraiser, The Great Sports Legends Dinner, Dalton describes himself as “all in” on the mission.
Looking to the future, Marc Buoniconti hopes to see The Miami Project’s work continue to expand. “My biggest dream is for our researchers to find a way to fully repair the nervous system,” he said. “When we do that, we’ll change the entire landscape for paralysis and so many other neuro conditions. We’ll give so many people their lives back. That’s what keeps me going, and that’s what makes every struggle to this point worth it.”
Fact Checker
Verify the accuracy of this article using The Disinformation Commission analysis and real-time sources.
8 Comments
Overcoming paralysis through science and determination is truly inspiring. It’s great to see the Miami Project expanding its research into other neurological conditions like Alzheimer’s and Parkinson’s. Steady funding and an unwavering commitment to finding solutions are key to driving progress in such complex medical challenges.
It’s heartening to see an organization like the Miami Project refuse to accept the status quo when it comes to paralysis and other neurological conditions. Their relentless approach to finding solutions, even in the face of skepticism, is truly admirable. The expansion of their work into Alzheimer’s and Parkinson’s is a logical and welcome development.
This article is a fascinating look at the Miami Project’s evolution from a specialized paralysis research center to a broader neurological research institute. Their ability to adapt and expand their mission while maintaining their core focus is admirable. I’m particularly interested in learning more about their work with Elon Musk’s Neuralink technology and how it might contribute to their overall research efforts.
This article highlights the importance of persistent, well-funded scientific research in driving medical progress. The Miami Project’s ability to continuously adapt and expand its mission while maintaining its core focus on paralysis is truly impressive. I wonder if their collaborative approach, involving partners like Elon Musk’s Neuralink, has been a key factor in their success.
This is a remarkable story of persistence and innovation in the pursuit of medical breakthroughs. The Miami Project’s ability to raise over $550 million and broaden its research agenda is a testament to the power of vision and dedication. I’m curious to see how their work with Elon Musk’s Neuralink technology develops.
The potential for brain-computer interfaces to aid in treating neurological disorders is quite exciting. I’ll be following the Miami Project’s research in this area with great interest.
The Miami Project’s story is a powerful reminder that with enough determination and the right resources, seemingly intractable medical challenges can be overcome. The breadth of their research agenda, from paralysis to Alzheimer’s and Parkinson’s, demonstrates their commitment to improving the lives of those affected by neurological disorders. I’m curious to learn more about their specific research focus areas and milestones.
The Miami Project’s story is a testament to the power of perseverance and a relentless pursuit of scientific breakthroughs. Overcoming skepticism and securing steady funding over four decades is no easy feat, but their commitment to finding solutions for paralysis and other neurological conditions is truly inspiring. I’m eager to see how their research into brain-computer interfaces evolves and impacts the field.